DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study on the Use of Intraoperative Neurophysiological Monitoring in Spinal Cord Stimulator Trials

Withdrawn

Conditions: Lumbar Radiculopathy
SCS
Pain, Chronic

First Posted Date: 2022-09-15

Last Posted Date: 2023-04-28

Lead Sponsor: University of Chicago

Registration Number: NCT05540756

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)

Phase 4

Recruiting

Conditions: Metrorrhagia
Pelvic Pain
Menorrhagia
Leiomyoma

Interventions: Drug: Myfembree Oral Product

First Posted Date: 2022-09-14

Last Posted Date: 2024-05-08

Lead Sponsor: University of Chicago

Target Recruit Count: 136

Registration Number: NCT05538689

Locations: 🇺🇸
University of Chicago River East, Chicago, Illinois, United States
🇺🇸
University of Chicago DCAM, Chicago, Illinois, United States
🇺🇸
University of Chicago South Loop, Chicago, Illinois, United States

and more 3 locations

Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Not Applicable

Recruiting

Conditions: Preeclampsia Postpartum

Interventions: Device: Remote Patient Monitoring

First Posted Date: 2022-09-10

Last Posted Date: 2024-06-14

Lead Sponsor: University of Chicago

Target Recruit Count: 70

Registration Number: NCT05534932

Locations: 🇺🇸
University of Chicago Hospital, Chicago, Illinois, United States

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Phase 1

Recruiting

Conditions: Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Head and Neck Carcinoma
Head and Neck Cancer Stage IV
Head and Neck Cancers - Throat

Interventions: Radiation: Chemoradiation
Drug: Pamiparib
Drug: Hydroxyurea
Drug: Fluorouracil (5FU)
Drug: Tislelizumab

First Posted Date: 2022-09-02

Last Posted Date: 2024-11-22

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT05526924

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

Phase 4

Recruiting

Conditions: Elevated Serum PSA

Interventions: Drug: Ibuprofen 400 mg

First Posted Date: 2022-08-23

Last Posted Date: 2025-03-30

Lead Sponsor: University of Chicago

Target Recruit Count: 200

Registration Number: NCT05512754

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Albany Medical College, Albany, New York, United States
🇺🇸
The Pennsylvania State University at The Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities

Not Applicable

Completed

Conditions: COVID-19

Interventions: Other: Motivational
Other: Education

First Posted Date: 2022-08-15

Last Posted Date: 2025-05-18

Lead Sponsor: University of Chicago

Target Recruit Count: 778

Registration Number: NCT05500274

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Oxytocin Pharmacokinetics and Pharmacodynamics

Phase 2

Recruiting

Conditions: Blood Loss
Post Partum Hemorrhage
Cesarean Section Complications

Interventions: Drug: deuterated oxytocin (d5OT)

First Posted Date: 2022-08-04

Last Posted Date: 2025-05-06

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT05488457

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Stanford University, Stanford, California, United States

Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia

Completed

Conditions: Leukemia, Myeloid
Acute Myeloid Leukemia

Interventions: Device: Bioelectrical Impedence Analysis Device
Other: 6 Minute Walk Test
Diagnostic Test: Computed Tomography Scans to Measure Skeletal Muscular Index
Diagnostic Test: Blood Test/Blood Draw
Other: Hand Grip Strength Test

First Posted Date: 2022-07-14

Last Posted Date: 2025-04-30

Lead Sponsor: University of Chicago

Target Recruit Count: 239

Registration Number: NCT05458258

Locations: 🇺🇸
University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Phase 2

Recruiting

Conditions: Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma
Head and Neck Neoplasms
Head Cancer
Throat Carcinoma

Interventions: Drug: Pembrolizumab
Drug: Carboplatin
Drug: Paclitaxel

First Posted Date: 2022-06-15

Last Posted Date: 2024-12-05

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT05420948

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients

Completed

Conditions: Heart Assist Device
Heart Failure
Hyponatremic

Interventions: Drug: tolvaptan

First Posted Date: 2022-06-07

Last Posted Date: 2022-06-07

Lead Sponsor: University of Chicago

Target Recruit Count: 28

Registration Number: NCT05408104

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy